Trends in multidrug-resistant tuberculosis

Multidrug-resistant tuberculosis (MDR-TB) is an increasing global problem. The extent and burden of MDR-TB varies significantly from country to country and region to region. Globally, about three per cent of all newly diagnosed patients have MDR-TB and the proportion is higher in patients who had previously received anti-tuberculosis (anti-TB) treatment reflecting the failure of programs designed to ensure complete cure of patients with tuberculosis. The management of MDR-TB is a challenge that should be undertaken by experienced clinicians at centers equipped with reliable laboratory services and implementation of DOTS-Plus strategy.

Saved in:
Bibliographic Details
Main Authors: Dias-Baptista,I. M. F., Usó,S. M. R. S., Marcondes-Machado,J.
Format: Digital revista
Language:English
Published: Centro de Estudos de Venenos e Animais Peçonhentos (CEVAP/UNESP) 2008
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1678-91992008000200003
Tags: Add Tag
No Tags, Be the first to tag this record!